EU approves Kimberly-Clark's Kenvue acquisition; Dilek to acquire Kotex, Camelia and Record
The EU approved Kimberly-Clark's $40B acquisition of Kenvue, requiring divestment of Kotex, Camelia, and Record brands in the EEA to Dilek. The Commission cited competition concerns in Czechia, Estonia, and Slovakia. Dilek was approved as the buyer, with an independent trustee to monitor compliance. The deal was notified on 25 August 2026.
How this was made
The 30-second read
Why it matters
Regulatory approval removes a major hurdle, enabling the deal to proceed while imposing divestiture costs that could affect margins.
Market read
The approval clears a $40 bn cross‑border deal, creating immediate trading opportunities for KMB and KENV.
What to watch
Financing structure and integration costs may be larger than disclosed, affecting long‑term earnings.
Background
The European Commission cleared the Kimberly-Clark–Kenvue merger after requiring the seller to divest its Kotex, Camelia and Record brands in the EEA to Turkish firm Dilek.
Ticker impact
EU approval of Kimberly-Clark's $40 bn acquisition of Kenvue, subject to divestitures, creates a material M&A event for the company.
likely pressure as the market prices in the acquisition cost and required divestitures
Large‑scale acquisition announced and approved today; investors typically react to the financing burden and regulatory commitments.
Market effects
Consolidation in consumer health and hygiene may intensify competition dynamics for peers.
EU market sees a major cross‑border M&A, potentially influencing other pending deals in the region.
The $40 bn transaction is one of the largest global consumer‑health deals this year.
Counterpoint
The divestiture commitments could unlock value for competitors, offsetting any acquisition premium.
Key entities
- CompanyKimberly-Clark Corporation
US consumer products giant acquiring Kenvue.
- CompanyKenvue Inc.
Consumer health spin‑off of Johnson & Johnson, target of the acquisition.
- CompanyDilek Gıda Üretim ve Pazarlama Ticaret A.Ş.
Turkish buyer of the divested feminine‑hygiene brands.
